Smolarz B, Nowak AZ, Romanowicz H. Breast cancer—epidemiology, classification, pathogenesis and treatment (review of literature). Cancers. 2022;14(10):2569.
Article CAS PubMed PubMed Central Google Scholar
Tao Z, Shi A, Lu C, Song T, Zhang Z, Zhao J. Breast cancer: epidemiology and etiology. Cell Biochem Biophys. 2015;72(2):333–8.
Article CAS PubMed Google Scholar
Feng Y, Spezia M, Huang S, et al. Breast cancer development and progression: risk factors, cancer stem cells, signaling pathways, genomics, and molecular pathogenesis. Genes Dis. 2018;5(2):77–106.
Article CAS PubMed PubMed Central Google Scholar
Jones LW, Haykowsky MJ, Swartz JJ, Douglas PS, Mackey JR. Early breast cancer therapy and cardiovascular injury. J Am Coll Cardiol. 2007;50(15):1435–41.
Bogdanov S. Royal jelly, bee brood: composition, health, medicine: a review. Lipids. 2011;3(8):8–19.
Ramadan MF, Al-Ghamdi A. Bioactive compounds and health-promoting properties of royal jelly: a review. J Func Foods. 2012;4(1):39–52.
Pasupuleti VR, Sammugam L, Ramesh N, Gan SH. Honey, propolis, and royal jelly: a comprehensive review of their biological actions and health benefits. Oxid Med Cell Longev. 2017;2017:1259510.
Zhang S, Shao Q, Geng H, Su S. The effect of royal jelly on the growth of breast cancer in mice. Oncol Lett. 2017;14(6):7615–21.
PubMed PubMed Central Google Scholar
Miyata Y, Sakai H. Anti-cancer and protective effects of royal jelly for therapy-induced toxicities in malignancies. Int J Mol Sci. 2018;19(10):3270.
Article PubMed PubMed Central Google Scholar
Nakaya M, Onda H, Sasaki K, Yukiyoshi A, Tachibana H, Yamada K. Effect of royal jelly on bisphenol A-induced proliferation of human breast cancer cells. Biosci Biotechnol Biochem. 2007;71(1):253–5.
Article CAS PubMed Google Scholar
Mishima S, Suzuki K-M, Isohama Y, et al. Royal jelly has estrogenic effects in vitro and in vivo. J Ethnopharmacol. 2005;101(1–3):215–20.
Amirshahi T, Najafi G, Nejati V. Protective effect of royal jelly on fertility and biochemical parameters in bleomycin- induced male rats. Iran J Reprod Med. 2014;12(3):209.
PubMed PubMed Central Google Scholar
Folkerd E, Dowsett M. Sex hormones and breast cancer risk and prognosis. Breast. 2013;22:S38–43.
Farhat GN, Parimi N, Chlebowski RT, et al. Sex hormone levels and risk of breast cancer with estrogen plus progestin. J Natl Cancer Inst. 2013;105(19):1496–503.
Article CAS PubMed PubMed Central Google Scholar
Seitz HK, Maurer B. The relationship between alcohol metabolism, estrogen levels, and breast cancer risk. Alcohol Research. 2007;30(1):42.
Hankinson SE, Eliassen AH. Endogenous estrogen, testosterone and progesterone levels in relation to breast cancer risk. J Steroid Biochem Mol Biol. 2007;106(1–5):24–30.
Article CAS PubMed PubMed Central Google Scholar
Pastore LM, Carter RA, Hulka BS, Wells E. Self-reported urogenital symptoms in postmenopausal women: women’s health initiative. Maturitas. 2004;49(4):292–303.
Yip CH, Rhodes A. Estrogen and progesterone receptors in breast cancer. Future Oncol. 2014;10(14):2293–301.
Article CAS PubMed Google Scholar
Fisher B, Redmond C, Brown A, et al. Treatment of primary breast cancer with chemotherapy and tamoxifen. N Engl J Med. 1981;305(1):1–6.
Article CAS PubMed Google Scholar
Pujol P, Hilsenbeck SG, Chamness GC, Elledge RM. Rising levels of estrogen receptor in breast cancer over 2 decades. Cancer. 1994;74(5):1601–6.
Article CAS PubMed Google Scholar
Costa B, Amorim I, Gärtner F, Vale N. Understanding breast cancer: from conventional therapies to repurposed drugs. Eur J Pharm Sci. 2020:105401.
Lee WL, Cheng MH, Chao HT, Wang PH. The role of selective estrogen receptor modulators on breast cancer: from tamoxifen to raloxifene. Taiwan J Obstet Gynecol. 2008;47(1):24–31.
Shanle EK, Xu W. Selectively targeting estrogen receptors for cancer treatment. Adv Drug Deliv Rev. 2010;62(13):1265–76.
Article CAS PubMed PubMed Central Google Scholar
Vogel CL, Johnston MA, Capers C, Braccia D. Toremifene for breast cancer: a review of 20 years of data. Clin Breast Cancer. 2014;14(1):1–9.
Article CAS PubMed Google Scholar
Mirkin S, Pickar JH. Selective estrogen receptor modulators (SERMs): a review of clinical data. Maturitas. 2015;80(1):52–7.
Article CAS PubMed Google Scholar
Buzdar AU. Fulvestrant-a novel estrogen receptor antagonist for the treatment of advanced breast cancer. Drugs Today. 2008;44(9):679–92.
Hiscox S, Davies EL, Barrett-Lee P. Aromatase inhibitors in breast cancer. Maturitas. 2009;63(4):275–9.
Article CAS PubMed Google Scholar
Engel J, Schally AV, Buchholz S, Seitz S, Emons G, Ortmann O. Targeted chemotherapy of endometrial, ovarian and breast cancers with cytotoxic analogs of luteinizing hormone-releasing hormone (LHRH). Arch Gynecol Obstet. 2012;286(2):437–42.
Article CAS PubMed Google Scholar
Emons G, Sindermann H, Engel J, Schally AV, Gründker C. Luteinizing hormone-releasing hormone receptor-targeted chemotherapy using AN-152. Neuroendocrinology. 2009;90(1):15–8.
Article CAS PubMed Google Scholar
Emons G, Schally AV. The use of luteinizing hormone releasing hormone agonists and antagonists in gynaecological cancers. Hum Reprod. 1994;9(7):1364–79.
Article CAS PubMed Google Scholar
Khazaei F, Ghanbari E, Khazaei M. Improved hormonal and oxidative changes by Royal Jelly in the rat model of PCOS: an experimental study. Int J Reprod Biomed. 2021;19(6):515.
CAS PubMed PubMed Central Google Scholar
Ab Hamid N, Abu Bakar AB, Mat Zain AA, Nik Hussain NH, Othman ZA, Zakaria Z, Mohamed M. Composition of Royal Jelly (RJ) and its anti-androgenic effect on reproductive parameters in a polycystic ovarian syndrome (PCOS) animal model. Antioxidants. 2020;9(6):499.
Article CAS PubMed PubMed Central Google Scholar
Liu Y, Wu D, Wang K, Chen H, Xu H, Zong W, Zhang N, Zhao L, Lin Z, Ji T. Dose-dependent effects of royal jelly on estrogen-and progesterone-induced mammary gland hyperplasia in rats. Mol Nutr Food Res. 2022;66(5):2100355.
Ghanbari E, Khazaei M, Khazaei M, Nejati V. Royal jelly promotes ovarian follicles growth and increases steroid hormones in immature rats. 2018; 11 (4): 263-269. https://doi.org/10.22074/ijfs.2018.5156.Received.2016;22:263-269
Zhang S, Shao Q, Shen Z, Su S. Immunomodulatory response of 4T1 murine breast cancer model to camellia royal jelly. Biomed Res. 2017;28(3):1223–30.
Al-Eisa R, Al-Nahari H. The attenuating effect of Royal Jelly on Hormonal Parameters in Aluminum Chloride (AlCl3) intoxicated rats. Int J Pharm Res Allied Sci. 2017;6(2):70–85.
Ahmed MM, El-Shazly SA, Alkafafy ME, Mohamed AA, Mousa AA. Protective potential of royal jelly against cadmium-induced infertility in male rats. Andrologia. 2018;50(5):e12996.
Ghanbari E, Nejati V, Najafi G, Khazaei M, Babaei M. Study on the effect of royal jelly on reproductive parameters in streptozotocin-induced diabetic rats. Int J Fertil Steril. 2015;9(1):113.
CAS PubMed PubMed Central Google Scholar
Zahmatkesh E, Najafi G, Nejati V, Heidari R. Protective effect of royal jelly on the sperm parameters and testosterone level and lipid peroxidation in adult mice treated with oxymetholone. Avicenna J Phytomed. 2014;4(1):43.
CAS PubMed PubMed Central Google Scholar
Najafi G, Nejati V, ShalizarJalali A, Zahmatkesh E. Protective role of royal jelly in oxymetholone-induced oxidative injury in mouse testis. Iran J Toxicol. 2014;8(25):1073–80.
Yang A, Zhou M, Zhang L, et al. Influence of royal jelly on the reproductive function of puberty male rats. Food Chem Toxicol. 2012;50(6):1834–40.
Article CAS PubMed Google Scholar
Abd-Allah SM. Effect of royal jelly on the fertilizing ability of buffalo spermatozoa in vitro. J Buffalo Sci. 2012;1(1):1–4.
Elnagar SA. Royal jelly counteracts bucks’“summer infertility.” Anim Reprod Sci. 2010;121(1–2):174–80.
留言 (0)